<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schlicting, Erin G</style></author><author><style face="normal" font="default" size="100%">Johnson, Mark E</style></author><author><style face="normal" font="default" size="100%">Brems, Christiane</style></author><author><style face="normal" font="default" size="100%">Wells, Rebecca S</style></author><author><style face="normal" font="default" size="100%">Fisher, Dennis G</style></author><author><style face="normal" font="default" size="100%">Reynolds, Grace</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Validity of Injecting Drug Users' Self Report of Hepatitis A, B, and C</style></title><secondary-title><style face="normal" font="default" size="100%">American Society for Clinical Laboratory Science</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2003</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2003-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">99-106</style></pages><doi><style  face="normal" font="default" size="100%">10.29074/ascls.16.2.99</style></doi><volume><style face="normal" font="default" size="100%">16</style></volume><issue><style face="normal" font="default" size="100%">2</style></issue><abstract><style  face="normal" font="default" size="100%">OBJECTIVE: To test the validity of drug users self-reports of diseases associated with drug use, in this case hepatitis A, B, and C.DESIGN: Injecting drug users (n = 653) were recruited and asked whether they had been diagnosed previously with hepatitis A, B, and/or C. These self-report data were compared to total hepatitis A antibody, hepatitis B core antibody, and hepatitis C antibody seromarkers as a means of determining the validity of the self-reported information.SETTING: Anchorage, Alaska.PARTICIPANTS: Criteria for inclusion included being at least 18-years old; testing positive on urinalysis for cocaine metabolites, amphetamine, or morphine; having visible signs of injection (track marks).INTERVENTION: Serological testing for hepatitis A, B, and C.MAIN OUTCOME: Findings indicate high specificity, low sensitivity, and low kappa coefficients for all three self-report measures.RESULTS: Subgroup analyses revealed significant differences in sensitivity associated with previous substance abuse treatment experience for hepatitis B self-report and with gender for hepatitis C self-report.CONCLUSION: Given the low sensitivity, the validity of drug users, self-reported information on hepatitis should be considered with caution.ABBREVIATIONS: HAV = hepatitis A virus; HBV = hepatitis B virus; HCV = hepatitis C virus; HIV = human immunodeficiency virus; IDU = injection drug user; STD = sexually transmitted disease.</style></abstract></record></records></xml>